A 6-Month Study Comparing Efficacy, Safety, and Tolerability of the Preservative-free Fixed Combination of Tafluprost 0.0015% and Timolol 0.5% versus Each of Its Individual Preservative-Free Components

Pfeiffer N., Traverso C.E., Lorenz K., Saarela V., Liinamaa J., Uusitalo H., Astakhov Y., Boiko E., Ropo A.

2014
Advances in Therapy

Therapeutic Area

Glaucoma
Categories

Clinical development

Affiliations

Department of Ophthalmology, Mainz University Medical Center, Langenbeckstr. 1, Mainz, 55101, Germany; Clinica Oculistica, Di.N.O.G.M.I., University of Genoa, IRCCS Azienda Ospedaliera Universitaria San Martino-IST, Genoa, Italy; Department of Ophthalmology, Medical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland; Department of Ophthalmology, University of Tampere and TAUH Eye Center, Tampere, Finland; First Pavlov State Medical University of St. Petersburg, St. Petersburg, Russian Federation; Military Medical Academy, St. Petersburg, Russian Federation; Santen Oy, Clinical Research and Medical Affairs, Helsinki, Finland

Related Publications

Felodipine re-positioned as a neuroprotectant via improved optic nerve head blood circulation in retinal ischemic rabbits and ocular hypertensive rats

Taniguchi T, Akaishi T, Hata T, Yamashita R, Esaki Y, Morofuji R, Okabe K, Fuwa M, Yamamoto Y, Guo L, Choi S, Luong V, Ota T, Sharif NA, Cordeiro MF, Kageyama M.

A Study of 24-h Efficacy and Safety of Sepetaprost vs. Latanoprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

Konstas A.G.; Garhöfer G.; Lübke Y.; Voykov B.; Ropo A.

Valproic Acid Application to Modify Post Surgical Fibrosis in a Model of Minimally Invasive Bleb Surgery

Lo P.F.; Gunawan M.; Yap Z.L.; Leong C.; Kwek F.; Varadarajan J.; Wang X.; Kageyama M.; Wong T.T.

View all Glaucoma publications